Formulations with abuse-deterrent properties target the known or expected routes of abuse, such as crushing in order to snort or dissolving in order to inject, for the specific opioid drug substance. The science of abuse deterrence is relatively new, and both the formulation technologies and the analytical, clinical, and statistical methods for evaluating those technologies are rapidly evolving.
Abuse-deterrent is not the same as abuse-proof
The fact that a product has FDA-approved labeling describing abuse-deterrent properties does not mean the product is impossible to abuse or that these properties necessarily prevent overdose and death – currently marketed technologies do not effectively deter one of the most common forms of opioid abuse – swallowing a number of intact tablets or capsules. Because opioid medications must in the end be able to deliver the opioid to the patient, there may always be some potential for abuse of these products.
He is talking about Pfizer ALO-02 NOT SequestOx!!!!!
This is what the CEO Nasrat stated on the Jul 18 CC about SequestOx
Nasrat Comments CC Jul 18
Quote: "They made no comment on the human abuse liability studies because again they were solid and they work; or with the withdrawal study or the efficacy study – the Bunionectomy. This is great news for Elite’s ADT platform."
Notice he says using a common solvent such as water is wanted to extract the product. He also says there are ways the product can be abused. Let's not ignore FACTS the company has already communicated.